Crossref journal-article
Elsevier BV
Journal of Thrombosis and Haemostasis (78)
Bibliography

GAILANI, D., & RENNÉ, T. (2007). The intrinsic pathway of coagulation: a target for treating thromboembolic disease? Journal of Thrombosis and Haemostasis, 5(6), 1106–1112.

Authors 2
  1. D. GAILANI (first)
  2. T. RENNÉ (additional)
References 67 Referenced 163
  1. 10.1182/blood.V70.1.1.1 / Blood / The coagulation‐kinin pathway of human plasma by Kaplan (1987)
  2. 10.1016/S0065-2776(08)60837-8 / Adv Immunol / The biochemistry and pathophysiology of the contact system of plasma by Cochrane (1982)
  3. 10.1016/S0065-2776(08)60599-4 / Adv Immunol / The intrinsic coagulation/kinin‐forming cascade: assembly in plasma and cell surfaces in inflammation by Kaplan (1997)
  4. 10.1182/blood.V90.10.3819 / Blood / Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes by Colman (1997)
  5. 10.1038/202498a0 / Nature / An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier by Macfarlane (1964)
  6. 10.1126/science.145.3638.1310 / Science / Waterfall sequence for intrinsic clotting by Davie (1964)
  7. 10.1021/bi00107a001 / Biochemistry / The coagulation cascade: initiation, maintenance and regulation by Davie (1991)
  8. {'key': '10.1111/j.1538-7836.2007.02446.x_bb0045', 'series-title': 'Hematology: Basic Principles and Practice', 'first-page': '2001', 'article-title': 'Laboratory evaluation of hemostatic disorders', 'author': 'Rand', 'year': '2005'} / Hematology: Basic Principles and Practice / Laboratory evaluation of hemostatic disorders by Rand (2005)
  9. 10.1074/jbc.M105221200 / J Biol Chem / Characterization of the H‐kininogen‐binding site on factor XI: a comparison of factor XI and plasma prekallikrein by Renne (2002)
  10. {'key': '10.1111/j.1538-7836.2007.02446.x_bb0055', 'series-title': 'Hematology: Basic Principles and Practice', 'first-page': '2047', 'article-title': 'Clinical aspects and therapy of hemophilia', 'author': 'Lozier', 'year': '2005'} / Hematology: Basic Principles and Practice / Clinical aspects and therapy of hemophilia by Lozier (2005)
  11. 10.1056/NEJM199107183250303 / N Eng J Med / Factor XI deficiency in Ashkenazi Jews in Israel by Asakai (1991)
  12. {'key': '10.1111/j.1538-7836.2007.02446.x_bb0065', 'series-title': 'The Metabolic and Molecular Bases of Inherited Disease', 'first-page': '4433', 'article-title': 'Factor XI and the contact system', 'author': 'Gailani', 'year': '2001'} / The Metabolic and Molecular Bases of Inherited Disease / Factor XI and the contact system by Gailani (2001)
  13. 10.1182/blood.V90.10.3962 / Blood / A coagulation factor IX‐deficient mouse model for human hemophilia B by Lin (1997)
  14. 10.1097/00001721-199703000-00008 / Blood Coag Fibrinol / A murine model of factor XI deficiency by Gailani (1997)
  15. 10.1160/TH04-04-0250 / Thromb Haemost / Targeted deletion of murine coagulation factor XII gene‐a model for contact phase activation in vivo by Pauer (2004)
  16. 10.1073/pnas.0932632100 / Proc Nat Acad Sci USA / The evolution of vertebrate coagulation as viewed from a comparison of puffer fish and sea squirt genomes by Jiang (2003)
  17. 10.1016/S0049-3848(97)00307-1 / Thromb Res / Whale Hageman factor (factor XII): prevented production due to pseudogene conversion by Semba (1998)
  18. 10.1021/bi00485a001 / Biochem / Regulation of coagulation by a multivalent Kunitz‐type inhibitor by Broze (1990)
  19. 10.1074/jbc.M312827200 / J Biol Chem / Formation of factor IXa and Xa by the extrinsic pathway: differential regulation by tissue factor pathway inhibitor and antithrombin by Lu (2004)
  20. 10.1182/blood-2003-12-4352 / Blood / Platelet deposition inhibits tissue factor activity: in vitro clots are impermeable to factor Xa by Hathcock (2004)
  21. 10.1182/blood-2004-03-0935 / Blood / Hematopoietic cell‐derived microparticle tissue factor contributes to fibrin formation during thrombus propagation by Chou (2004)
  22. 10.1182/blood-2004-06-2225 / Blood / Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall by Day (2005)
  23. 10.1021/bi972113+ / Biochem / Prothrombin is a cofactor for binding of factor XI to the platelet surface and for platelet‐mediated factor XI activation by thrombin by Baglia (1998)
  24. 10.1074/jbc.M000464200 / J Biol Chem / Thrombin‐mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa by Baglia (2000)
  25. 10.1126/science.1652157 / Science / Factor XI activation in a revised model of blood coagulation by Gailani (1991)
  26. 10.1182/blood.V86.8.3035.3035 / Blood / Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis by Von Dem Borne (1995)
  27. 10.1074/jbc.270.24.14477 / J Biol Chem / Purification and characterization of thrombin activatable fibrinolysis inhibitor (TAFI), a thrombin‐activatable fibrinolysis inhibitor by Bajzar (1995)
  28. 10.1172/JCI119412 / J Clin Invest / Thrombin‐mediated activation of factor XI results in a thrombin‐activatable fibrinolysis inhibitor‐dependent inhibition of fibrinolysis by Von dem Borne (1997)
  29. 10.1055/s-0037-1615964 / Thromb Haemost / The role of factor XI in thrombin generation induced by low concentrations of tissue factor by Keularts (2001)
  30. 10.1182/blood.V91.12.4581 / Blood / Blood coagulation in hemophilia A and hemophilia C by Cawthern (1998)
  31. 10.1073/pnas.0507195103 / Proc Natl Acad Sci USA / Polyphosphate modulates blood coagulation and fibrinolysis by Smith (2006)
  32. 10.1084/jem.20050664 / J Exp Med / Defective thrombus formation in mice lacking coagulation factor XII by Renne (2005)
  33. {'key': '10.1111/j.1538-7836.2007.02446.x_bb0170', 'first-page': '347', 'article-title': 'Activation of blood clotting factors by microbial proteinases', 'volume': '121', 'author': 'Kaminishi', 'year': '1994', 'journal-title': 'FEBS Microbiol Lett'} / FEBS Microbiol Lett / Activation of blood clotting factors by microbial proteinases by Kaminishi (1994)
  34. 10.1084/jem.192.10.1415 / J Exp Med / Severe lung lesions caused by Salmonella are prevented by inhibition of the contact system by Persson (2000)
  35. 10.1016/S0021-9258(19)50297-6 / J Biol Chem / Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells by Reddigari (1987)
  36. 10.4049/jimmunol.175.5.3377 / J Immunol / Local bradykinin formation is controlled by glycosaminoglycans by Renne (2005)
  37. 10.1055/s-0037-1615837 / Thromb Haemost / Activation of the plasma/kallikrein system on cells: a revised hypothesis by Schmaier (1999)
  38. 10.1073/pnas.022626899 / Proc Natl Acad Sci USA / Heat shock protein 90 catalyzes activation of the prekallikrein‐kininogen complex in the absence of factor XII by Joseph (2002)
  39. 10.1182/blood-2003-07-2510 / Blood / Recombinant prolylcarboxypeptidase activates plasma prekallikrein by Shariat‐Madar (2004)
  40. 10.1074/jbc.273.50.33224 / J Biol Chem / A novel mechanism for bradykinin production at inflammatory sites. Diverse effects of a mixture of neutrophil elastase and mast cell tryptase versus tissue and plasma kallikreins on native and oxidized kininogens by Kozik (1998)
  41. 10.1111/j.1538-7836.2005.01236.x / J Thromb Haemost / Effects of factor IX or factor XI deficiency on ferric chloride‐induced carotid artery occlusion in mice by Wang (2005)
  42. 10.1172/JCI0212119 / J Clin Invest / Thrombin‐activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life by Nagashima (2002)
  43. 10.1172/JCI26987 / J Clin Invest / Thrombus formation in vivo by Furie (2005)
  44. {'key': '10.1111/j.1538-7836.2007.02446.x_bb0225', 'first-page': '66a', 'article-title': 'Factor XI deficient mice have reduced platelet accumulation and fibrin deposition after laser injury', 'volume': '104', 'author': 'Baird', 'year': '2004', 'journal-title': 'Blood'} / Blood / Factor XI deficient mice have reduced platelet accumulation and fibrin deposition after laser injury by Baird (2004)
  45. 10.1055/s-0037-1613081 / Thromb Haemost / FXI is essential for thrombus formation following FeCl3‐induced injury of the carotid artery in the mouse by Rosen (2002)
  46. 10.1084/jem.20052458 / J Exp Med / Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis by Kleinschnitz (2006)
  47. 10.1084/jem.190.1.91 / J Exp Med / Targeted inhibition of intrinsic coagulation limits cerebral injury in stroke without increasing intracerebral hemorrhage by Choudhri (1999)
  48. 10.1055/s-0037-1613209 / Thromb Haemost / Platelet activation and blood coagulation by Heemskerk (2002)
  49. 10.1182/blood.V57.1.106.106 / Blood / Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI by Walsh (1981)
  50. 10.1515/BC.2006.023 / Biol Chem / Platelets promote coagulation factor XII‐mediated proteolytic cascade systems in plasma by Johne (2006)
  51. 10.1056/NEJM200003093421004 / N Engl J Med / High levels of coagulation factor XI as a risk factor for venous thrombosis by Meijers (2000)
  52. 10.1182/blood-2005-12-023697 / Blood / Levels of intrinsic coagulation factors and the risk of myocardial infarction among men. Opposite and synergistic effects of factors XI and XII by Doggen (2006)
  53. 10.1046/j.1538-7836.2003.00195.x / J Thromb Haemost / Inherited factor XI deficiency confers no protection against acute myocardial infarction by Salomon (2003)
  54. 10.1309/QC259F09UNMKVP0R / Am J Clin Pathol / Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events by Yang (2006)
  55. 10.1172/JCI781 / J Clin Invest / Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti‐fibrinolytic factor by Minnema (1998)
  56. 10.1111/j.1538-7836.2006.01973.x / J Thromb Haemost / Factor XI contributes to thrombus propagation on injured neointima of the rabbit iliac artery by Yamashita (2006)
  57. 10.1182/blood-2003-01-0324 / Blood / Factor XI‐dependence of surface‐ and tissue factor‐initiated thrombus formation in primates by Gruber (2003)
  58. {'key': '10.1111/j.1538-7836.2007.02446.x_bb0295', 'first-page': '151', 'article-title': 'The George M. Kober lecture. The legacy of John Hageman: new dividends', 'volume': '98', 'author': 'Ratnoff', 'year': '1985', 'journal-title': 'Trans Assoc Am Physicians'} / Trans Assoc Am Physicians / The George M. Kober lecture. The legacy of John Hageman: new dividends by Ratnoff (1985)
  59. 10.1111/j.1365-2141.1994.tb04937.x / Br J Haematol / John Hageman’s factor and deep‐vein thrombosis: Leiden thrombophilia Study by Koster (1994)
  60. 10.1055/s-0037-1614368 / Thromb Haemost / Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency‐a study on 73 subjects from 14 Swiss families by Zeerleder (1999)
  61. 10.1023/B:THRO.0000037670.42776.cd / J Thromb Thrombolysis / The occasional venous thromboses seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: a study of prevalence in 21 Patients and review of the literature by Girolami (2004)
  62. 10.1161/01.ATV.17.10.2103 / Arterisocler Thromb Vasc Biol / Risk of coronary heart disease and activation of factor XII in middle aged men by Miller (1997)
  63. 10.1016/j.ahj.2003.07.012 / Am Heart J / Activated factor XII (FXIIa) predicts recurrent coronary events after acute myocardial infarction by Grundt (2004)
  64. {'key': '10.1111/j.1538-7836.2007.02446.x_bb0325', 'first-page': 'A30', 'article-title': 'Plasma activity of coagulation factor XII and all cause mortality in Vienna (ACMIV study) – evidence of a J‐shaped association of factor XII activity and overall survival', 'volume': '26', 'author': 'Endler', 'year': '2006', 'journal-title': 'Hämostasiologie'} / Hämostasiologie / Plasma activity of coagulation factor XII and all cause mortality in Vienna (ACMIV study) – evidence of a J‐shaped association of factor XII activity and overall survival by Endler (2006)
  65. 10.1182/blood-2005-02-0577 / Blood / The effects of intrinsic pathway protease deficiencies on plasminogen‐deficient mice by Cheng (2005)
  66. 10.1101/gad.9.7.794 / Genes Develop / Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction by Bugge (1995)
  67. 10.1016/S0002-9440(10)64529-4 / Am J Path / The development of bleomycin‐induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system by Swaisgood (2000)
Dates
Type When
Created 18 years, 2 months ago (May 26, 2007, 11:32 a.m.)
Deposited 2 years, 7 months ago (Jan. 15, 2023, 10:19 p.m.)
Indexed 2 weeks, 2 days ago (Aug. 6, 2025, 8:42 a.m.)
Issued 18 years, 2 months ago (June 1, 2007)
Published 18 years, 2 months ago (June 1, 2007)
Published Print 18 years, 2 months ago (June 1, 2007)
Funders 0

None

@article{GAILANI_2007, title={The intrinsic pathway of coagulation: a target for treating thromboembolic disease?}, volume={5}, ISSN={1538-7836}, url={http://dx.doi.org/10.1111/j.1538-7836.2007.02446.x}, DOI={10.1111/j.1538-7836.2007.02446.x}, number={6}, journal={Journal of Thrombosis and Haemostasis}, publisher={Elsevier BV}, author={GAILANI, D. and RENNÉ, T.}, year={2007}, month=jun, pages={1106–1112} }